(Q44804920)

6 December 2017

Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel (English)

1 reference

6 December 2017

Weiner E

1

1 reference

PubMed ID

975814

6 December 2017

Johansson ED

series ordinal

2

1 reference

6 December 2017

1 July 1976

1 reference

6 December 2017

1 reference

6 December 2017

14

1 reference

6 December 2017

1

1 reference

6 December 2017

81-92

1 reference

THE USE OF SILICONE RUBBER AS A CARRIER FOR PROLONGED DRUG THERAPY

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

Passage of Steroids Through Silicone Rubber

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

Fertility control in women with a progestogen released in microquantities from subcutaneous capsules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

Acceptability of long-term contraceptive steroid administration in humans by subcutaneous Silastic capsules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

One-Year Contraception with Norgestrienone Subdermal Silastic Implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

A preliminary report on the contraceptive use of subdermal implants containing norethindrone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

Contraceptive effectiveness of Silastic implants containing the progestin R-2323

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

Radioimmunoassay of serum progesterone in women receiving oral contraceptive steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

Radioimmunoassay of Plasma Progesterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

Inhibition of the positive feedback of oestradiol during treatment with subcutaneous implants of d-norgestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 3. Factors affecting steroid diffusion in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

Effect of norgestrel on corpus luteum function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

Effects of continuous daily administration of 0.3 mg of norehtindrone on the plasma levels of progesterone and on the urinary excretion of pregnanediol and total oestrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

Use of subcutaneous Silastic capsules for long-term steroid contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

THE ROLE OF PROGESTOGENS IN THE HORMONAL CONTROL OF FERTILITY.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2876%2980011-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0010-7824(76)80011-X

1 reference

6 December 2017

1 reference

PubMed ID

975814